Peter K. Miller - Sep 15, 2022 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Role
Chief Executive Officer, Director
Signature
/s/ Anthony Krick, Attorney-in-Fact
Stock symbol
OPTN
Transactions as of
Sep 15, 2022
Transactions value $
-$189,803
Form type
4
Date filed
9/20/2022, 05:30 PM
Previous filing
Jun 17, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPTN Common Stock Award $0 +10.9K +1.17% $0.00 941K Sep 15, 2022 Direct F1, F2
transaction OPTN Common Stock Sale -$171K -48.2K -5.13% $3.55 893K Sep 16, 2022 Direct F3
transaction OPTN Common Stock Sale -$18.6K -5.23K -0.59% $3.56 887K Sep 20, 2022 Direct F3
holding OPTN Common Stock 104K Sep 15, 2022 By: Deed of Trust Peter K. Miller, dated October 13, 2014
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of performance-based restricted stock units (Performance RSUs) on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to receive one share of common stock of OptiNose, Inc.
F2 Includes 14,170 shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on June 30, 2022 at a price of $1.50
F3 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.